Tag: Biocon

Pharma sector can be of $200 bn by 2030 on innovative drugs: Biocon chief

Research-based incentives to develop innovative drugs can help the domestic pharmaceutical sector to be worth $200 billion by 2030,

Biocon arm Biocon Biologics Ltd (BBL) has partnered with Sandoz for the distribution, sale, and promotion of Adalimumab (a

Biocon Biologics, a subsidiary of Biocon, on Monday announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in

Biologics major Bengaluru-based Biocon posted a 168 per cent year-on-year rise in its consolidated net profit for the September

The USFDA has “determined the inspection classification as ‘OAI’ (Official Action Indicated). The OAI status may cause delay and/or withholding

BENGALURU (Reuters) -Indian drugmaker Biocon Ltd on Monday appointed Peter Bains as the group’s chief executive officer, effective immediately.

Biopharma company Biocon’s wholly owned subsidiary, Biocon Generics, has acquired the oral solid dosage manufacturing facility of US-based Eywa

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltdannounced that HULIO injection, a biosimilar replacement for Humira (adalimumab), is now

The Canada Pension Plan Investment Board will sell 3.3 crore shares or 1.66 per cent of the shares Kotak Mahindra

India will be the shining light to the world driven by its youth who are ‘driving startups’ India will be